🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. Perflutren lipid

    United Therapeutics Europe Ltd

    Acute Spinal Cord Injury

    approved small molecule active

    1 trial

  2. Perineural infusion [continuous peripheral nerve block(s)]

    United Therapeutics Europe Ltd

    Phantom Limb Pain

    approved small molecule completed

    1 trial

  3. Pertussis containing vaccine

    United Therapeutics Europe Ltd

    Pregnancy Related

    approved mab active

    1 trial

  4. Pethidine

    Stoke Therapeutics

    Pain Relief in Labour

    approved small molecule completed

    1 trial

  5. Pharmacotherapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule completed

    1 trial

  6. Pharmacotherapy

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule active

    1 trial

  7. Pharmacotherapy for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial

  8. Phenoxybenzamine

    Atrium Therapeutics

    Pheochromocytoma

    approved small molecule completed

    1 trial

  9. Phenylephrine

    United Therapeutics Europe Ltd

    Spinal Anesthesia

    approved small molecule terminated

    1 trial

  10. Pimavanserin

    Acadia Pharmaceuticals B.V.

    Neurodegenerative Diseases

    approved small molecule active

    1 trial

  11. Pioglitazone 15mg

    United Therapeutics Europe Ltd

    High Altitude

    approved small molecule completed

    1 trial

  12. Placebo of rosuvastatin 10mg (tablet) as produced by Apotheek A15, Rosuvastatin tablet 10mg Apotheek A15

    Disc Medicine

    Statin-intolerance, High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)

    approved small molecule active

    1 trial

  13. Placebo used in this trial is a foodgrade, redried potato starch. It is a white powder with bland taste and free from objectionable odours. Insoluble in water with a temperature below 50 °C and most organic solvents, solution is slightly hazy. The product is intended for use in food., POTATO STARCH, SODIUM CHLORIDE, AMILORIDE

    Disc Medicine

    Autosomal Dominant Polycystic Kidney Disease

    approved small molecule active

    1 trial

  14. Plasma rich in growth factors

    Wuhan Createrna Science and Technology Co., Ltd

    Foot ulcers in diabetic patients with peripheral arterial disease

    approved small molecule active

    1 trial

  15. Popliteal nerve block including liposomal bupivacaine

    Pacira Ireland Limited

    Moderate-to-severely Painful Ankle Surgery

    approved small molecule active

    1 trial

  16. Prednisolone

    United Therapeutics Europe Ltd

    COPD Exacerbation

    approved small molecule completed

    1 trial

  17. Pregabalin

    Yung NA

    Diabetic Peripheral Neuropathy

    approved small molecule completed

    1 trial

  18. Pregabalin

    Vera Therapeutics

    Pain, Postoperative

    approved small molecule completed

    1 trial

  19. Prevenar 13

    United Therapeutics Europe Ltd

    Sepsis

    approved mab completed

    1 trial

  20. Prilocaine (Hyperbaric 2%)

    United Therapeutics Europe Ltd

    Cervical Incompetence in Pregnancy as Antepartum Condition

    approved small molecule active

    1 trial

  21. RITALINE L.P. 10 mg, gélule à libération prolongée

    Tour Hekla

    Attention Deficit Disorder with or without Hyperactivity (ADHD) is a neurodevelopmental disorder characterized by disabling symptoms of inattention and/or hyperactivity-impulsivity beginning before the age of 12 with significant personal, social, academic and/or occupational impact (American Psychiatric Association 2013). This disorder, whose prevalence is around 5% in children and adolescents, affects 2.6% of adults (American Psychiatric Association 2013; Song et al. 2021).

    approved small molecule active

    1 trial

  22. Rapid Acting insulin with pre-treatment of rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  23. Recombinant FSH (follitropin alpha)

    United Therapeutics Europe Ltd

    Ovulation Induction

    approved small molecule completed

    1 trial

  24. Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)

    United Therapeutics Europe Ltd

    Diarrhea

    approved mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources